BioTrillion, Inc. Company Profile

Background

Overview

BioTrillion, Inc., founded on January 2, 2018, is a San Francisco-based health technology startup specializing in AI-driven health monitoring solutions. The company's mission is to democratize healthcare by enabling individuals worldwide to access personalized health insights through their smartphones. BioTrillion's flagship product, BioEngine4D™, is an AI-powered digital biomarker platform that transforms smartphones into health monitoring devices capable of detecting early signs of diseases.

Mission and Vision

BioTrillion's mission is to unlock the power of smartphone technology to democratize healthcare, enabling over a billion people to access extraordinary, personalized health insights anytime, anywhere. The company's vision is to revolutionize health monitoring by leveraging existing smartphone sensors and AI to provide accessible and accurate health assessments.

Primary Area of Focus

The company focuses on developing non-invasive, contactless health monitoring solutions that utilize smartphone cameras and sensors to measure vital signs and detect early signs of diseases. This approach aims to make health monitoring more accessible and scalable, reaching individuals who may not have access to traditional healthcare settings.

Industry Significance

BioTrillion operates at the intersection of healthcare and technology, addressing the critical need for continuous, accessible health monitoring. By leveraging smartphones, the company aims to bridge the gap between clinical and life settings, providing real-time health insights that can lead to earlier disease detection and improved health outcomes.

Key Strategic Focus

Core Objectives

Democratization of Healthcare: Making health monitoring accessible to a global audience through smartphone technology.

Early Disease Detection: Utilizing AI to identify early signs of diseases, enabling timely intervention.

Scalability: Developing solutions that can be widely adopted without the need for specialized equipment.

Specific Areas of Specialization

Digital Biomarkers: Creating and validating digital biomarkers that can be measured using smartphone sensors.

AI and Computer Vision: Applying advanced AI algorithms to analyze physiological data captured via smartphones.

Mobile Health (mHealth): Developing applications that leverage mobile devices for health monitoring and management.

Key Technologies Utilized

BioEngine4D™ Platform: An AI-powered digital biomarker platform that analyzes data from smartphone sensors to detect early signs of diseases.

Computer Vision: Utilizing smartphone cameras to capture and analyze physiological data, such as facial features and movements.

Machine Learning: Employing machine learning algorithms to interpret complex health data and provide actionable insights.

Primary Markets Targeted

Consumers: Individuals seeking proactive health management and early disease detection.

Healthcare Providers: Clinicians and telehealth services aiming to enhance patient monitoring and care.

Pharmaceutical Companies: Utilizing the platform for decentralized clinical trials and drug development.

Insurance Companies: Employing the technology for health risk assessments and management.

Financials and Funding

Funding History

Seed Round: In August 2018, BioTrillion raised an undisclosed amount in a seed funding round.

Total Funds Raised

The company has raised a total of $1.25 million in funding to date.

Notable Investors

Specific investor details are not publicly disclosed.

Intended Utilization of Capital

Product Development: Enhancing the BioEngine4D platform and expanding the range of measurable biomarkers.

Market Expansion: Scaling operations to reach a broader consumer base and enter new markets.

Strategic Partnerships: Forming alliances with healthcare providers, pharmaceutical companies, and insurance firms to integrate the technology into existing systems.

Pipeline Development

Key Pipeline Candidates

HealthySelfie™ App: A mobile application that allows users to measure and monitor 10 clinically validated biomarkers through a 10-second face scan using only their smartphone.

Stages of Development

Prototype Stage: The HealthySelfie™ app is in the prototype stage, with ongoing development to refine its features and accuracy.

Target Conditions

Neurological Diseases: Early detection of conditions such as Alzheimer's disease and other cognitive impairments.

Cardiological Conditions: Monitoring vital signs related to heart health.

General Health Monitoring: Providing users with insights into overall health and wellness.

Anticipated Milestones

Product Launch: Expected to launch the HealthySelfie™ app to the public in the near future.

Clinical Validation: Ongoing studies to validate the accuracy and reliability of the biomarkers measured by the app.

Technological Platform and Innovation

Proprietary Technologies

BioEngine4D™ Platform: An AI-powered digital biomarker platform that analyzes data from smartphone sensors to detect early signs of diseases.

Significant Scientific Methods

Computer Vision: Utilizing smartphone cameras to capture and analyze physiological data, such as facial features and movements.

Machine Learning: Employing machine learning algorithms to interpret complex health data and provide actionable insights.

Leadership Team

Savan Devani – Founder & CEO

Professional Background: Over 15 years in the life sciences industry, including roles at Citigroup and Deutsche Bank, leading numerous financing and M&A deals totaling over $35 billion.

Key Contributions: Founded BioTrillion to leverage his expertise in life sciences and technology to revolutionize healthcare through smartphone-based health monitoring solutions.

Derrick Mo – Deep Learning Engineer

Professional Background: Experience in finance and deep learning, with previous roles at Sun Life Global Investments.

Key Contributions: Advances BioTrillion's commercial applications at the intersection of deep learning, computer vision, and physiology, focusing on the BioEngine4D platform and digital biomarkers.

Kegang Wang – Machine Learning Engineer

Professional Background: Research focused on extracting health information from facial image data.

Key Contributions: Applies cutting-edge techniques in computer vision AI for remote photoplethysmography (rPPG), enabling contactless health monitoring through smartphone cameras.

Competitor Profile

Market Insights and Dynamics

Market Size and Growth Potential: The digital health market is rapidly expanding, with increasing adoption of mobile health solutions and AI-driven health monitoring technologies.

Industry Trends: A shift towards decentralized healthcare, personalized medicine, and the integration of AI and machine learning in health diagnostics.

Competitor Analysis

Verily: Focuses on health data collection and analysis, with a range of health monitoring devices and platforms.

Evidation Health: Specializes in measuring health outcomes through real-world data, partnering with various health organizations.

Mindstrong Health: Develops digital biomarkers and remote monitoring tools for mental health conditions.

Sonde Health: Utilizes voice data to assess health conditions, particularly respiratory and mental health.

Brightlamp: Focuses on eye-tracking technology for assessing cognitive function and neurological health.

Soberlink: Provides remote alcohol monitoring solutions for individuals in recovery and professionals.

Strategic Collaborations and Partnerships

Aptar Digital Health Partnership: In June 2024, BioTrillion partnered with Aptar Digital Health to decentralize the detection, monitoring, and treatment of neurological and cardiological conditions, aiming to enhance patient experiences through innovative digital solutions.

Operational Insights

Strategic Considerations

Major Competitors: Companies like Verily, Evidation Health, and Mindstrong Health are significant competitors in the digital health and AI-driven health monitoring space.

Market Position: BioTrillion differentiates itself by focusing on smartphone-based health monitoring solutions that require no additional hardware, making health monitoring more accessible and scalable.

Competitive Advantages: The ability to measure multiple disease signs using existing smartphone devices, providing a comprehensive health assessment without the need for specialized equipment.